Based on these findings, numerous research studies show that combined inhibition of LSD1 and HDACs is more effective than the inhibition of a single enzyme in stopping the growth and migration of various tumors, including breast cancer, AML and glioblastoma. Here, KDM1A is linked to acute myeloid leukemia.